IAPP and Alzheimer disease: Further studies are needed to determine the association between the concentrations of amylin in peripheral blood and neurodegeneration and a randomized, double-blind, placebo-controlled clinical trial is required to examine the efficacy of the amylin analogue pramlintide for AD.